[The impact of the COVID-19 pandemic on the control of chronic diseases in primary care]. [PDF]
Caparrós Boixés G +3 more
europepmc +1 more source
Uso del Heberprot-P® en paciente con Pie Diabético
El pie diabético es una alteración clínica de base etiopatogénica neuropática e inducida por la hiperglucemia mantenida. Se presenta este caso clínico con el objetivo de mostrar la efectividad del uso del Heberprot-p® en el tratamiento del pie diabético.
Rafael Miranda Pedroso
doaj
Cross-cultural adaptation and validation of the Diabetic Foot Questionnaire (DiaFootQ) into Spanish Language. [PDF]
Ruiz-Muñoz M +5 more
europepmc +1 more source
Cholesterol goals, statin use and residual cardiovascular risk estimated by SMART score: Study of a Nicaraguan population. [PDF]
Rizo Rivera GO +6 more
europepmc +1 more source
Surgical treatment of diabetic foot: a spatial analysis, Ceará, Brazil, 2016-2021. [PDF]
Feitosa YS +6 more
europepmc +1 more source
[Effectiveness of a home kinesiology exercise plan on activity limitation in subjects with diabetic foot] [PDF]
Giménez V, Olsen MA.
europepmc +1 more source
Amniotic Membrane Restores Chronic Wound Features to Normal in a Keratinocyte TGF-β-Chronified Cell Model. [PDF]
Liarte S +5 more
europepmc +1 more source
Diabetic foot care and cardiovascular surgery in Peru: a looming crisis of centralism and unequal resource allocation. [PDF]
Cubas WS.
europepmc +1 more source
[Indicators of diabetes mellitus after liraglutide, sitagliptin/metformin, linagliptin, and sitagliptin]. [PDF]
Atonal-Flores B +2 more
europepmc +1 more source

